title: Lithium overcomes the influence of 5-HTTLPR gene polymorphism on antidepressant response to sleep deprivation.
authors.forename: Francesco
authors.initials: F
authors.lastname: Benedetti
authors.forename: Barbara
authors.initials: B
authors.lastname: Barbini
authors.forename: Alessandro
authors.initials: A
authors.lastname: Bernasconi
authors.forename: Mara Cigala
authors.initials: MC
authors.lastname: Fulgosi
authors.forename: Euridice
authors.initials: E
authors.lastname: Campori
authors.forename: Cristina
authors.initials: C
authors.lastname: Colombo
authors.forename: Sara
authors.initials: S
authors.lastname: Dallaspezia
authors.forename: Cristina
authors.initials: C
authors.lastname: Lorenzi
authors.forename: Adriana
authors.initials: A
authors.lastname: Pontiggia
authors.forename: Daniele
authors.initials: D
authors.lastname: Radaelli
authors.forename: Enrico
authors.initials: E
authors.lastname: Smeraldi
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D039721:Diagnostic and Statistical Manual of Mental Disorders; D005260:Female; D006801:Humans; D018020:Lithium Compounds / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010869:Pindolol / Q000627:therapeutic use; D011110:Polymorphism, Genetic; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D011618:Psychotic Disorders / Q000150:complications / Q000188:drug therapy; D058829:Serotonin 5-HT1 Receptor Antagonists; D012702:Serotonin Antagonists / Q000627:therapeutic use; D050486:Serotonin Plasma Membrane Transport Proteins / Q000235:genetics*; D012892:Sleep Deprivation / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D018020:Lithium Compounds; C493230:SLC6A4 protein, human; D058829:Serotonin 5-HT1 Receptor Antagonists; D012702:Serotonin Antagonists; D050486:Serotonin Plasma Membrane Transport Proteins; D010869:Pindolol